Middle East And Africa Regenerative Medicines Market By Product (Cell-Based & Acellular Products), Therapy (Cell Therapy, Gene Therapy, Tissue Engineering), And Application (Orthopedic, Dermatology, Cardiovascular) – Market Analysis, Size, Geographic Countries Analysis, Competitive Strategies Analysis And Forecasts (2016 To 2021)

Middle East And Africa Regenerative Medicines Market By Product (Cell-Based & Acellular Products), Therapy (Cell Therapy, Gene Therapy, Tissue Engineering), And Application (Orthopedic, Dermatology, Cardiovascular) – Market Analysis, Size, Geographic Countries Analysis, Competitive Strategies Analysis And Forecasts (2016 To 2021)

ID: 275 | Pages: 145 | September 2016 | Region: Middle East and Africa


Middle East and Africa regenerative medicines market is expected to reach USD 5.75 billion by 2021 from USD 2.03 billion in 2016, growing at a CAGR of 23.15% during the forecast period 2016-2021. Regenerative medicines repair, replace or regenerate human cells, tissues, or organs affected due to injury, disease, aging processes, congenital defects, and damage due to trauma. These medicines restore normal functions of cells & tissues. These medicines are available in different types such as genes, somatic cells, stem cells, and other types. Some of these medicines (such as stem cells) have the ability to proliferate, differentiate thereby restore the original structure of cells or tissues or organs. Regenerative medicines are used in varied range of degenerative disorders include cardiovascular, neurodegenerative diseases, dermatology, and orthopedic, among others. Majority of the researchers aim to focus on the development of innovative technologies to provide better regenerative medicines and effective healthcare treatment solutions to patients.

Increasing demand for improved healthcare solutions, rising funding from public & private organizations for the development of advanced healthcare solutions, and government initiatives to promote the development of regenerative medicine products are driving the growth of regenerative medicines market in the Middle East and Africa. However, inadequate number of healthcare professionals, insufficient healthcare infrastructure, and low adoption of regenerative medicine products due to poor economic status are some of the factors restraining the growth of regenerative medicines market in the Middle East and Africa.

Middle East and Africa regenerative medicines market is segmented based on product, therapy, and application. Based on product, the market is further sub-segmented as cell-based products and acellular products. Of these, cell-based products segment is estimated to account for larger share of Middle East and Africa regenerative medicines market by product in 2016. Further, Cell-based products segment is classified as autologous and allogeneic products. Based on therapy, the market is segmented as cell therapy, gene therapy, tissue engineering, and immunotherapy. Of these, cell therapy is estimated to command the highest share of the Middle East and Africa regenerative medicines market by therapy in 2016.

Based on application, the market is segmented as orthopedic & musculoskeletal spine, dermatology, central nervous system, cardiovascular, oncology, diabetes, and other applications. Among these, orthopedic & musculoskeletal spine is estimated to command the largest share of the Middle East and Africa regenerative medicines market by application in 2016.

On the basis of geographical areas, Middle East and Africa regenerative medicines market is segmented as Middle East and South Africa.

The key players in regenerative medicines market such as, Vertex Pharmaceuticals Incorporated (U.S.), Acelity L.P. Inc. (U.S.), Celgene Corporation (U.S.), StemCells, Inc. (U.S.), Organogenesis Inc.  (U.S.), NuVasive, Inc. (U.S.), Vericel Corporation (Genzyme) (U.S.), Japan Tissue Engineering Co., Ltd. (Japan), Cytori Therapeutics Inc. (U.S.), Advantagene, Inc. (U.S.), and Mesoblast Ltd. (Australia).

1. Introduction                                                 

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                       

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 New Developments                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                    

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

5. Market Segmentation                                                              

                5.1 Introduction                                               

                5.2 Product                                        

                                5.2.1 Introduction                           

                                5.2.2 Cell-Based Products                            

                                                5.2.2.1 Autologous Cell-Based Products

                                                5.2.2.2 Allogeneic Cell-Based Products  

                                5.2.3 Acellular Products                

                5.3 Therapy                                       

                                5.3.1 Introduction                           

                                5.3.2 Cell Therapy                           

                                5.3.3 Gene Therapy                       

                                5.3.4 Tissue Engineering                               

                                5.3.5 Immunotherapy                   

                5.4 Application                                 

                                5.4.1 Introduction                           

                                5.4.2 Orthopedic & Musculoskeletal Spine                           

                                5.4.3 Dermatology                          

                                5.4.4 Cardiovascular                       

                                5.4.5 Central Nervous System                   

                                5.4.6 Oncology                 

                                5.4.7 Diabetes                  

                                5.4.8 Other Applications                               

6. Geographical Analysis                                                              

                6.5.1 Introduction                                           

                6.5.2 Middle East                                             

                6.5.2 South Africa                                            

7. Strategic Analysis                                                       

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

8. Market Leaders' Analysis                                                        

                8.1 Vertex Pharmaceuticals Incorporated (U.S.)                                

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Strategic Evaluation and Operations                            

                                8.1.4 Financial analysis                  

                                8.1.5 Legal issues                             

                                8.1.6 Recent Developments                       

                                8.1.7 SWOT analysis                       

                                8.1.8 Analyst View                          

                8.2 Acelity L.P. Inc. (U.S.)                                             

                8.3 Celgene Corporation (U.S.)                                 

                8.4 StemCells, Inc. (U.S.)                                              

                8.5 Organogenesis Inc.  (U.S.)                                    

                8.6 NuVasive, Inc. (U.S.)                                              

                8.7 Vericel Corporation (Genzyme) (U.S.)                                            

                8.8 Cytori Therapeutics Inc. (U.S.)                                            

                8.9 Advantagene, Inc. (U.S.)                                      

                8.10 Mesoblast Ltd. (Australia)                                  

9. Competitive Landscape                                                           

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

10. Expert Opinions                                                        

                10.1 Market Outlook                                     

                10.2 Investment Opportunities                                 

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1.  Middle East & Africa Regenerative Medicines Market By Region, From 2016-2021 (USD Billion)
  2. Middle East & Africa Regenerative Medicines Market By Product, From 2016-2021 (USD Billion)
  3. Middle East & Africa Cell-Based Products Regenerative Medicines Market By Region, From 2016-2021 (USD Billion)
  4. Middle East & Africa Acellular Products Regenerative Medicines Market By Region, From 2016-2021 (USD Billion)
  5. Middle East & Africa Regenerative Medicines Market By Therapy, From 2016-2021 (USD Billion)
  6. Middle East & Africa Cell Therapy Regenerative Medicines Market By Region, From 2016-2021 (USD Billion)
  7. Middle East & Africa Gene Therapy Regenerative Medicines Market By Region, From 2016-2021 (USD Billion)
  8. Middle East & Africa Tissue Engineering Regenerative Medicines Market By Region, From 2016-2021 (USD Billion)
  9. Middle East & Africa Immunotherapy Regenerative Medicines Market By Region, From 2016-2021 (USD Billion)
  10. Middle East & Africa Regenerative Medicines Market By Application, From 2016-2021 (USD Billion)
  11. Middle East & Africa Orthopedic & Musculoskeletal Spine Regenerative Medicines Market By Region, From 2016-2021 (USD Billion)
  12. Middle East & Africa Dermatology Regenerative Medicines Market By Region, From 2016-2021 (USD Billion)
  13. Middle East & Africa Cardiovascular Regenerative Medicines Market By Region, From 2016-2021 (USD Billion)
  14. Middle East & Africa Central Nervous System Regenerative Medicines Market By Region, From 2016-2021 (USD Billion)
  15. Middle East & Africa Oncology Regenerative Medicines Market By Region, From 2016-2021 (USD Billion)
  16. Middle East & Africa Diabetes Regenerative Medicines Market By Region, From 2016-2021 (USD Billion)
  17. Middle East & Africa Other Applications of Regenerative Medicines Market By Region, From 2016-2021 (USD Billion)
  18. Middle East Regenerative Medicines Market By Product, From 2016-2021 (USD Billion)
  19. Middle East Regenerative Medicines Market By Therapy, From 2016-2021 (USD Billion)
  20. Middle East Regenerative Medicines Market By Application, From 2016-2021 (USD Billion)
  21. Africa Regenerative Medicines Market By Product, From 2016-2021 (USD Billion)
  22. Africa Regenerative Medicines Market By Therapy, From 2016-2021 (USD Billion)
  23. Africa Regenerative Medicines Market By Application, From 2016-2021 (USD Billion)
  24. Middle East & Africa Cell-Based Products Regenerative Medicines Market By Type, From 2016-2021 (USD Billion)
  25. Middle East & Africa Autologous Cell-Based Products Regenerative Medicines Market By Region, From 2016-2021 (USD Billion)
  26. Middle East & Africa Allogeneic Cell-Based Products Regenerative Medicines Market By Region, From 2016-2021 (USD Billion)
  27. Middle East Cell-Based Products Regenerative Medicines Market By Type, From 2016-2021 (USD Billion)
  28. Africa Cell-Based Products Regenerative Medicines Market By Type, From 2016-2021 (USD Billion)
Middle East And Africa Metaxalone Market By Indication (Bone Pain, Muscle Pain, Tunnel Syndromes, Joint Pain And Others), By End User (Hospitals, Clinics And Others) And By Region - Industry Analysis, Size, Share, G...
Latin America Metaxalone Market By Indication (Bone Pain, Muscle Pain, Tunnel Syndromes, Joint Pain And Others), By End User (Hospitals, Clinics And Others) And By Region - Industry Analysis, Size, Share, Growth, Tr...
Asia Pacific Metaxalone Market By Indication (Bone Pain, Muscle Pain, Tunnel Syndromes, Joint Pain And Others), By End User (Hospitals, Clinics And Others) And By Region - Industry Analysis, Size, Share, Growth, Tre...
Europe Metaxalone Market By Indication (Bone Pain, Muscle Pain, Tunnel Syndromes, Joint Pain And Others), By End User (Hospitals, Clinics And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, A...
North America Metaxalone Market By Indication (Bone Pain, Muscle Pain, Tunnel Syndromes, Joint Pain And Others), By End User (Hospitals, Clinics And Others) And By Region - Industry Analysis, Size, Share, Growth, Tr...
Metaxalone Market By Indication (Bone Pain, Muscle Pain, Tunnel Syndromes, Joint Pain And Others), By End User (Hospitals, Clinics And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Fore...
Middle East And Africa Narcolepsy Drugs Market By Type (Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, And Others), By Indication (Daytime Extre...
Latin America Narcolepsy Drugs Market By Type (Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, And Others), By Indication (Daytime Extreme Sleepi...
Asia Pacific Narcolepsy Drugs Market By Type (Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, And Others), By Indication (Daytime Extreme Sleepin...
Europe Narcolepsy Drugs Market By Type (Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, And Others), By Indication (Daytime Extreme Sleepiness, C...
North America Narcolepsy Drugs Market By Type (Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, And Others), By Indication (Daytime Extreme Sleepi...
Narcolepsy Drugs Market By Type (Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, And Others), By Indication (Daytime Extreme Sleepiness, Cataplex...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.